We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bayer Acknowledges it Did Not Disclose Trasylol Data to FDA
Bayer Acknowledges it Did Not Disclose Trasylol Data to FDA
October 2, 2006
Just over a week after an FDA advisory committee decided Bayer Pharmaceuticals' blood-loss prevention drug Trasylol was safe and effective, the agency said study data Bayer just revealed shows the drug increases the risk of death, stroke, heart failure and kidney damage.